As of 3:59pm ET
| +0.79 / +0.64%|
The 8 analysts offering 12-month price forecasts for Bio-Techne Corp have a median target of 125.00, with a high estimate of 140.00 and a low estimate of 110.00. The median estimate represents a +0.60% increase from the last price of 124.25.
The current consensus among 9 polled investment analysts is to Buy stock in Bio-Techne Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.